Is the Risk Worth the Reward? Critical Factors to Consider for Your Value-based Care Strategy

April 20, 2016 Seth Blackley

Provider-Sponsored Health Plans (PSHPs) have long been viewed as the ultimate endpoint for value-based health care models. With health care reform ushering in a clear shift towards value, the industry has experienced a renewed interest in PSHPs. The changing dynamics of the US health care delivery system – new payment models, declining reimbursement and the expansion of government programs – are leading many providers to believe that formerly insurmountable challenges are more achievable than ever before. With key industry reports like Standard & Poor giving PSHPs a positive outlook, the looming question is no longer “when” to launch a PSHP, but “how”?

Join us for a complimentary webinar that answers the following questions and more:

What are the benefits of a PSHP?
How is launching a PSHP now different than in the 1990s?
What options do I have when it comes to ownership vs. partnership?
What are the critical factors that most health systems fail to consider?

About the Author

Seth Blackley is chief executive officer and co-founder of Evolent Health, as well as a member of Evolent's board of directors. As CEO he oversees all aspects of strategy, growth and execution for the company. Prior to Evolent Health, Seth was the executive director of corporate development at The Advisory Board Company. Seth started his career as an analyst in the Washington, D.C. office of McKinsey & Company. He also serves on the board of directors for GoHealth, a leading urgent care company. He earned a BS from The University of North Carolina at Chapel Hill, where he graduated with highest honors, and his MBA from the Harvard Business School. Seth and his three children live in Arlington, Virginia.
Follow on Twitter Follow on Linkedin Visit Website More Content by Seth Blackley

Previous Video

Clinician or Coder: Engaging Physicians for Risk Adjustment Success

Our experts help you determine solutions with physicians, for physicians, to ensure success for all stakeho...

Next Video

Next Gen ACO: How to Eliminate Your Risk and Maximize Your Return

Leverage Evolent's experience as an operational partner to multiple Next Gen participants and learn the key...

Return to Home

Is the Risk Worth the Reward? Critical Factors to Consider for Your Value-based Care Strategy

About the Author

Previous Video

Next Video

Most Recent Videos

Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and lasting impact of COVID

In this video update from SOMOS Community Care, Dr. Ramon Tallaj discusses the move from crisis to recovery.

Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.

This second update from SOMOS, a network of 2,500 New York City primary care physicians, highlights new lessons learned to help move the nation from crisis to recovery.

This on-demand webinar from a network of 2,500 New York City primary care physicians shares best practices for responding to COVID-19 infections in some of the nation’s most vulnerable communities.

Moving to value-based arrangements for high-dollar and high-variation specialties like oncology is often complicated by the complexity of care, an unpredictable pipeline of innovation, and surging dru

Hear firsthand from Cancer Care Specialists of Illinois (CCSI), a community-based oncology practice, about achieving success in the OCM program and how they are leveraging New Century Health’s risk mi

Population health is a central component of value-based care. However, despite significant investment, the ability to generate value varies greatly from one organization to the next. Why is this?

Hear from risk adjustment experts on the best practices you can implement to minimize execution risk and engage your entire physician network in your program

Dr. James Porter, CMO of Deaconess Health System and Evolent's Chris Dawe discuss why Deaconess joined the NextGen ACO program, what they learned, and why their partnership with Evolent is essential.

Our experts help you determine solutions with physicians, for physicians, to ensure success for all stakeholders in Risk Adjustment.

Leverage Evolent's experience as an operational partner to multiple Next Gen participants and learn the keys to succeeding in the Next Gen ACO program.